Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1953 1
1956 1
1957 3
1958 2
1959 5
1960 1
1961 2
1962 2
1963 6
1964 4
1965 4
1966 2
1967 9
1968 2
1969 4
1970 4
1971 1
1972 2
1973 1
1974 1
1977 3
1982 1
1983 2
1985 1
1987 2
1988 3
1989 1
1991 2
1992 1
2010 1
2014 1
2015 3
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Results by year
Filters applied: . Clear all
Page 1
HER2 activating mutations are targets for colorectal cancer treatment.
Kavuri SM, Jain N, Galimi F, Cottino F, Leto SM, Migliardi G, Searleman AC, Shen W, Monsey J, Trusolino L, Jacobs SA, Bertotti A, Bose R. Kavuri SM, et al. Among authors: cottino f. Cancer Discov. 2015 Aug;5(8):832-41. doi: 10.1158/2159-8290.CD-14-1211. Cancer Discov. 2015. PMID: 26243863 Free PMC article.
The genomic landscape of response to EGFR blockade in colorectal cancer.
Bertotti A, Papp E, Jones S, Adleff V, Anagnostou V, Lupo B, Sausen M, Phallen J, Hruban CA, Tokheim C, Niknafs N, Nesselbush M, Lytle K, Sassi F, Cottino F, Migliardi G, Zanella ER, Ribero D, Russolillo N, Mellano A, Muratore A, Paraluppi G, Salizzoni M, Marsoni S, Kragh M, Lantto J, Cassingena A, Li QK, Karchin R, Scharpf R, Sartore-Bianchi A, Siena S, Diaz LA Jr, Trusolino L, Velculescu VE. Bertotti A, et al. Among authors: cottino f. Nature. 2015 Oct 8;526(7572):263-7. doi: 10.1038/nature14969. Epub 2015 Sep 30. Nature. 2015. PMID: 26416732 Free PMC article.
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models.
Belli V, Matrone N, Napolitano S, Migliardi G, Cottino F, Bertotti A, Trusolino L, Martinelli E, Morgillo F, Ciardiello D, De Falco V, Giunta EF, Bracale U, Ciardiello F, Troiani T. Belli V, et al. Among authors: cottino f. J Exp Clin Cancer Res. 2019 Jun 4;38(1):236. doi: 10.1186/s13046-019-1230-z. J Exp Clin Cancer Res. 2019. PMID: 31164152 Free PMC article.
ENDEMIC CRETINISM IN PIEDMONT.
COSTA A, COTTINO F, MORTARA M, VOGLIAZZO U. COSTA A, et al. Among authors: cottino f. Panminerva Med. 1964 Jul-Aug;6:250-9. Panminerva Med. 1964. PMID: 14181932 Review. No abstract available.
Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3.
Sun C, Hobor S, Bertotti A, Zecchin D, Huang S, Galimi F, Cottino F, Prahallad A, Grernrum W, Tzani A, Schlicker A, Wessels LF, Smit EF, Thunnissen E, Halonen P, Lieftink C, Beijersbergen RL, Di Nicolantonio F, Bardelli A, Trusolino L, Bernards R. Sun C, et al. Among authors: cottino f. Cell Rep. 2014 Apr 10;7(1):86-93. doi: 10.1016/j.celrep.2014.02.045. Epub 2014 Mar 27. Cell Rep. 2014. PMID: 24685132 Free article.
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies.
Zanella ER, Galimi F, Sassi F, Migliardi G, Cottino F, Leto SM, Lupo B, Erriquez J, Isella C, Comoglio PM, Medico E, Tejpar S, Budinská E, Trusolino L, Bertotti A. Zanella ER, et al. Among authors: cottino f. Sci Transl Med. 2015 Jan 28;7(272):272ra12. doi: 10.1126/scitranslmed.3010445. Sci Transl Med. 2015. PMID: 25632036 Free article.
[Diagnosis and therapy of hot thyroid nodules].
Cottino F, Zoppetti G, Curino G. Cottino F, et al. Minerva Med. 1970 Jul 28;61(59-60):3221-31. Minerva Med. 1970. PMID: 5432515 Italian. No abstract available.
[CONSIDERATIONS ON THE PERCHLORATE TEST].
COSTA A, COTTINO F, ZOPPETTI G. COSTA A, et al. Among authors: cottino f. Minerva Nucl. 1963 May;7:208-10. Minerva Nucl. 1963. PMID: 14056634 Italian. No abstract available.
80 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page